Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
18.56
-0.94 (-4.82%)
May 18, 2026, 4:00 PM EDT - Market closed

AAPG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,7722,449----
Market Cap Growth
-20.76%-----
Enterprise Value
1,7032,2060000
Last Close Price
18.5626.24----
PE Ratio
--13.15----
PS Ratio
21.5929.84----
PB Ratio
9.2912.94----
P/TBV Ratio
1.251.76----
P/FCF Ratio
--14.26----
P/OCF Ratio
--14.59----
EV/Sales Ratio
20.7526.88----
EV/EBITDA Ratio
--12.87----
EV/EBIT Ratio
--12.00----
EV/FCF Ratio
--12.84----
Debt / Equity Ratio
0.570.573.2416.693.120.84
Debt / EBITDA Ratio
-1.65-1.65-5.66-2.23-2.14-1.13
Debt / FCF Ratio
-1.65-1.65-12.30-2.33-2.09-1.05
Net Debt / Equity Ratio
-0.37-0.371.5411.620.74-0.53
Net Debt / EBITDA Ratio
0.410.41-1.38-0.87-0.360.69
Net Debt / FCF Ratio
0.410.41-3.00-0.91-0.350.64
Asset Turnover
0.170.170.380.080.070.01
Inventory Turnover
2.782.782.562.383.291.69
Quick Ratio
1.661.661.151.331.764.98
Current Ratio
1.791.791.261.441.865.22
Return on Equity (ROE)
-154.39%-154.56%-235.32%-386.28%-107.45%-75.18%
Return on Assets (ROA)
-39.29%-39.29%-15.56%-33.40%-31.08%-39.59%
Return on Invested Capital (ROIC)
-122.18%-122.18%-37.32%-83.61%-92.75%-129.70%
Return on Capital Employed (ROCE)
-68.19%-68.19%-25.71%-51.04%-39.80%-48.77%
Earnings Yield
-10.03%-7.60%----
FCF Yield
-9.97%-7.01%----
Buyback Yield / Dilution
-17.90%-17.90%-7.00%-7.06%-3.56%-17.93%
Total Shareholder Return
-17.90%-17.90%-7.00%-7.06%-3.56%-17.93%
Updated Mar 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q